Cargando…
Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma
BACKGROUND: Diagnosing pancreatic ductal adenocarcinoma (PDAC) in the setting of metastasis with an unknown primary remains very challenging due to the lack of specific biomarkers. HNF-1B has been characterized as an important transcription factor for pancreatic development and was reported as a bio...
Autores principales: | Yang, Michelle X., Coates, Ryan F., Ambaye, Abiy, Gardner, Juli-Anne, Zubarick, Richard, Gao, Yuan, Skelly, Joan, Liu, James G., Mino-Kenudson, Mari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062876/ https://www.ncbi.nlm.nih.gov/pubmed/30065837 http://dx.doi.org/10.1186/s40364-018-0139-6 |
Ejemplares similares
-
Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma
por: Okubo, Satoshi, et al.
Publicado: (2019) -
Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems
por: Matsuda, Yoko, et al.
Publicado: (2020) -
Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival
por: Pergolini, Ilaria, et al.
Publicado: (2017) -
Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis
por: Quilichini, Evans, et al.
Publicado: (2019) -
Current and Future Therapies for Pancreatic Ductal Adenocarcinoma
por: Sally, Áine, et al.
Publicado: (2022)